← Leaderboards
Chuanshu Huang
New York University School Of Medicine
$11,325,976
Attributed
$11,868,760
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–18$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$11,868,760 · 8
By mechanism
R01$8,597,530 · 6
P01$3,271,230 · 2
Top collaborators
- Xianglin Shi1 shared
- Hong Sun1 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Markus Schober$8,962,767
- Dimitris G. Placantonakis$5,377,533
- Agnel Sfeir$14,727,073
- Aristotelis Tsirigos$7,163,614
- Max Costa$33,497,930
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsMolecularBaseIn VitroIn VivoDesignMediatingCellsMalignant NeoplasmsMouse ModelLinkCarcinogenesisSuccessTissuesProtein OverexpressionMalignant Neoplasm Of Urinary BladderProteinsCancer CellTumorigenesisInhibitor/AntagonistLungOverexpressionCell LineMutation
Grant awards (37)
SESN2 and therapeutic effect of Isohapontigenin (ISO)$422,057
R01 · FY2018 · CA · contact PI
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO)$351,713
R01 · FY2018 · CA · contact PI
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO)$351,713
R01 · FY2017 · CA · contact PI
Novel Role of XIAP in Bladder Cancer Invasion$351,362
P01 · FY2017 · CA · contact PI
Reagent/Service Core$303,852
P01 · FY2017 · CA · contact PI
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO)$351,713
R01 · FY2016 · CA · contact PI
Novel Role of XIAP in Bladder Cancer Invasion$351,362
P01 · FY2016 · CA · contact PI
Reagent/Service Core$303,852
P01 · FY2016 · CA · contact PI
Molecular Mechanisms of Nickel-induced Tumorigenicity.$279,902
R01 · FY2016 · CA · contact PI
Novel Role of XIAP in Bladder Cancer Invasion$351,362
P01 · FY2015 · CA · contact PI
Reagent/Service Core$303,852
P01 · FY2015 · CA · contact PI
Molecular Mechanisms of Nickel-induced Tumorigenicity.$279,902
R01 · FY2015 · CA · contact PI
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO)$341,162
R01 · FY2014 · CA · contact PI
Novel Role of XIAP in Bladder Cancer Invasion$340,821
P01 · FY2014 · CA · contact PI
Reagent/Service Core$294,735
P01 · FY2014 · CA · contact PI
Molecular Mechanisms of Nickel-induced Tumorigenicity.$271,505
R01 · FY2014 · CA · contact PI
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO)$351,713
R01 · FY2013 · CA · contact PI
Novel Role of XIAP in Bladder Cancer Invasion$349,338
P01 · FY2013 · CA · contact PI
Reagent/Service Core$320,694
P01 · FY2013 · CA · contact PI
Molecular Mechanisms of Nickel-induced Tumorigenicity.$263,108
R01 · FY2013 · CA · contact PI
Molecular Mechanisms of Nickel-induced Tumorigenicity.$25,001
R01 · FY2012 · CA · contact PI
Molecular Mechanisms of Nickel-induced Tumorigenicity.$279,902
R01 · FY2011 · CA · contact PI
Mechanisms of As-Induced Carcinogenesis$663,511
R01 · FY2009 · CA
Mechanisms of Tumor Promotion Effects of B[a]PDE$335,669
R01 · FY2008 · ES · contact PI
Molecular Mechanisms of Nickel-Induced Tumorigenicity$295,647
R01 · FY2008 · CA · contact PI
Mechanisms of Tumor Promotion Effects of B[a]PDE$342,519
R01 · FY2007 · ES · contact PI
Molecular Mechanisms of Nickel-Induced Tumorigenicity$295,647
R01 · FY2007 · CA · contact PI
Effects of Arsenic on PI-3K Signaling Pathway$277,798
R01 · FY2007 · CA · contact PI
Mechanisms of Tumor Promotion Effects of B[a]PDE$352,749
R01 · FY2006 · ES · contact PI
Molecular Mechanisms of Nickel-Induced Tumorigenicity$304,477
R01 · FY2006 · CA · contact PI
Effects of Arsenic on PI-3K Signaling Pathway$270,647
R01 · FY2006 · CA · contact PI
Mechanisms of Tumor Promotion Effects of B[a]PDE$361,238
R01 · FY2005 · ES
Molecular Mechanisms of Nickel-Induced Tumorigenicity$311,805
R01 · FY2005 · CA
Effects of Arsenic on PI-3K Signaling Pathway$277,160
R01 · FY2005 · CA
Mechanisms of Tumor Promotion Effects of B[a]PDE$355,371
R01 · FY2004 · ES
Molecular Mechanisms of Nickel-Induced Tumorigenicity$306,741
R01 · FY2004 · CA
Effects of Arsenic on PI-3K Signaling Pathway$277,160
R01 · FY2004 · CA